Cellosaurus TMhep39 (CVCL_B6DP)
| Cell line name | TMhep39 |
|---|---|
| Synonyms | TMHepTG3960 x 2984 x 4912 39; TMHepTG3960 x 2984 x 4912 line 39 |
| Accession | CVCL_B6DP |
| Resource Identification Initiative | To cite this cell line use: TMhep39 (RRID:CVCL_B6DP) |
| Comments | Characteristics: Established from a triple transgenic mice that contains 1) a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1, 2) a human SERPINA1 promoter driving the expression of SV40 T-antigen and 3) a human F9 promoter driving the expression of F9 (PubMed=1369183). Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3551; F9. Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1. Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc. Transformant: Myc. Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
| Disease | Hepatocellular carcinoma of the mouse (NCIt: C38756) |
| Species of origin | Mus musculus (Mouse)
(NCBI Taxonomy: 10090)
Breed/subspecies: C57BL/6 x SJL transgenic TG3960 x TG2984 x TG4912. |
| Category | Cancer cell line |
| Publications | PubMed=1369183; DOI=10.1007/BF02521733 Patent=US5814716 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q112041797 |
| Entry history | |
| Entry creation | 17-Mar-2022 |
| Last entry update | 19-Dec-2024 |
| Version number | 6 |